Avail Emerges as Leader in New Health + Tech Category: Procedural Telemedicine

Avail Emerges as Leader in New Health + Tech Category: Procedural Telemedicine

Today we’re proud to announce that Avail Medsystems has closed a $100 million Series B financing, led by our friends at D1 Capital, with participation from new investor 8VC and existing backers Lux, Coatue and Sonder Capital. Lux led Avail’s Series A financing in 2018, and we’ve been privileged to work with Avail founder and CEO Daniel Hawkins, as well as board members Fred Moll (previously founder and CEO of both Auris Health and Intuitive Surgical) and industry veteran Jay Watkins.

Procedural telemedicine is a distinct, new discipline in the wider field of telemedicine and telehealth. Avail developed purpose-built hardware and software to meet unique requirements for surgeons to consult real-time with outside experts during procedures. The business model enables best quality care for patients, creates new step function collaboration efficiencies with outside experts, and helps de-risk access to non-elective surgery from local, regional, or global threats.

Seeing what others can’t

When a patient goes in for surgery, the operating room is often packed with medical experts. In addition to the surgeon, these experts can include clinical support, hospital leadership, medical students, an observing physician, the department chief — and to the great surprise of those outside of industry, the medical device sales rep. Squeezing all of these people into the operating room not only increases the risk of infection, but it is also a logistics challenge to make sure the right experts are in the room, at the right time.

Device reps are often left sitting in waiting rooms by the coffee machine or dashing from hospital to hospital for surgeon support and relationship maintenance. Physicians-in-training or specialized doctors travel great distances and work long hours in order to receive or share knowledge.

Different from doctor-patient telemedicine, procedural telemedicine uses technology to help physicians in an operating room connect with remote healthcare experts, medical device experts, or medical trainees, regardless of their location, to collaborate during procedures or for clinical education and training. Examples of uses include medical device industry remote support of surgeries, peer-to-peer physician proctoring during new technology introductions, and live case broadcasts during medical education meetings.

Avail is pioneering the surgery room of the future… today. COVID-19 was a force multiplier for the company’s growth and relevance. As scheduled surgeries came to a halt, and still aren’t being performed at full capacity, procedural telemedicine offered a solution for medical device support and physician-to-physician collaboration when access was restricted. Now, the Avail technology that was built specifically for the operating room is the go-to model for decreasing infection risk, eliminating the need for extensive travel, and creating a network of experts for universal access to healthcare knowledge.

We’re thrilled to be part of Avail’s story, using a modern technology platform to more evenly distribute higher quality healthcare, benefiting patients in the U.S. and globally.

written by
Peter Hébert
Co-founder and Managing Partner

Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. His goal: to seek out founders developing things most people thought would not work, yet if they did, would become so intrinsic to our way of life that we would someday take them for granted.

Today Lux supports a wide range of once-impossible-sounding advancements, including 3D printing and imaging, nuclear waste cleanup, machine learning and robots that fly or conduct microsurgery.

Imitation is suicide. –Ralph Waldo Emerson

Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson for up to $6 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Everspin Technologies (NASDAQ: MRAM), Lux Research (acquired by Bregal Sagemount), Luxtera (acquired by Cisco for $660 million), Matterport (NASDAQ: MTTR), SiBEAM (acquired by Silicon Image), Transphorm (NASDAQ: TGAN), and Vium (acquired by Recursion). Peter launched the firm’s Lux Health + Tech investment strategy, including the Nasdaq Lux Health Tech Index (NASDAQ: NQHTEC) and helped launch the First Trust Nasdaq Lux Digital Health Solutions ETF (NASDAQ: EKG). Current investments include Avail, Bright Machines, Carbon Health, Flex Logix, Ingenuity, Lux Health Tech Acquisition Corp. (NASDAQ: LUXA), Mendaera, Ripcord, Thematic and Vosbor. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm. In 2021, he co-founded Thematic as a next generation index and ETF developer and today serves as its Chairman.

Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.

written by

Avail Emerges as Leader in New Health + Tech Category: Procedural Telemedicine

visit source
No items found.
Text Link